We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Clinical Labs Under ACA: Challenge And Opportunity

Law360, New York (January 16, 2014, 12:48 AM EST) -- Diagnostic clinical laboratory and pathology tests are the backbone of health care for patients, providing invaluable information regarding the presence or absence of disease, the progression of illness, and the effects of treatment. More recently, the scientific and technological advances in the development of genetic and genomic tests present even greater opportunities for practitioners to determine an individual’s predisposition toward disease or response to a drug regimen.

The accelerated movement toward personalized, evidence-based medicine, pushed forward by the demands of providers, payors and patients alike, underscores the critical need for and immense value of these diagnostic tests. This value, however, has...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS